-
1
-
-
33645757920
-
Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
-
Moe S, Drüeke T, Cunningham J etal. Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006;69:1945-1953.
-
(2006)
Kidney Int
, vol.69
, pp. 1945-1953
-
-
Moe, S.1
Drüeke, T.2
Cunningham, J.3
-
2
-
-
84876423710
-
CKD-MBD Guideline Working Group; Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder
-
Fukagawa M, Yokoyama K, Koiwa F etal. CKD-MBD Guideline Working Group; Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 2013;17:247-288.
-
(2013)
Ther Apher Dial
, vol.17
, pp. 247-288
-
-
Fukagawa, M.1
Yokoyama, K.2
Koiwa, F.3
-
3
-
-
0342588049
-
Arterial stiffening and vascular calcifications in end-stage renal disease
-
Guerin AP, London GM, Marchais SJ etal. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014-1021.
-
(2000)
Nephrol Dial Transplant
, vol.15
, pp. 1014-1021
-
-
Guerin, A.P.1
London, G.M.2
Marchais, S.J.3
-
4
-
-
0035725506
-
Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
-
Blacher J, Guerin AP, Pannier B etal. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-942.
-
(2001)
Hypertension
, vol.38
, pp. 938-942
-
-
Blacher, J.1
Guerin, A.P.2
Pannier, B.3
-
5
-
-
0032962093
-
Effect of histamine H2-receptor antagonist on the phosphorus-binding abilities of calcium carbonate and calcium lactate in hemodialysis patients
-
Takahashi N, Shoji T, Matsubara K etal. Effect of histamine H2-receptor antagonist on the phosphorus-binding abilities of calcium carbonate and calcium lactate in hemodialysis patients. J Am Soc Nephrol 1999;10:1090-1094.
-
(1999)
J Am Soc Nephrol
, vol.10
, pp. 1090-1094
-
-
Takahashi, N.1
Shoji, T.2
Matsubara, K.3
-
6
-
-
0036310682
-
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
-
Treat to Goal Working Group
-
Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.
-
(2002)
Kidney Int
, vol.62
, pp. 245-252
-
-
Chertow, G.M.1
Burke, S.K.2
Raggi, P.3
-
7
-
-
31644446801
-
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
-
Block GA, Spiegel DM, Ehrlich J etal. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005;68:1815-1824.
-
(2005)
Kidney Int
, vol.68
, pp. 1815-1824
-
-
Block, G.A.1
Spiegel, D.M.2
Ehrlich, J.3
-
8
-
-
29144468253
-
Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients
-
Iwasaki Y, Takami H, Tani M etal. Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients. Ther Apher Dial 2005;9:347-351.
-
(2005)
Ther Apher Dial
, vol.9
, pp. 347-351
-
-
Iwasaki, Y.1
Takami, H.2
Tani, M.3
-
9
-
-
29144448055
-
Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan
-
ROD 21 Clinical Research Group
-
Koiwa E, Onoda N, Kato H etal. ROD 21 Clinical Research Group. Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan. Ther Apher Dial 2005;9:340-346.
-
(2005)
Ther Apher Dial
, vol.9
, pp. 340-346
-
-
Koiwa, E.1
Onoda, N.2
Kato, H.3
-
10
-
-
84898027950
-
Randomized controlled trial of bixalomer versus sevelamer hydrochloride in hemodialysis patients with hyperphosphatemia
-
the Bixalomer Study Group
-
Akizawa T, Origasa H, Kameoka C, Kaneko Y, Kawasaki S, the Bixalomer Study Group. Randomized controlled trial of bixalomer versus sevelamer hydrochloride in hemodialysis patients with hyperphosphatemia. Ther Apher Dial 2014;18:122-131.
-
(2014)
Ther Apher Dial
, vol.18
, pp. 122-131
-
-
Akizawa, T.1
Origasa, H.2
Kameoka, C.3
Kaneko, Y.4
Kawasaki, S.5
-
11
-
-
0028868486
-
Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer
-
Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046-1052.
-
(1995)
Scand J Gastroenterol
, vol.30
, pp. 1046-1052
-
-
Dimenäs, E.1
Glise, H.2
Hallerbäck, B.3
Hernqvist, H.4
Svedlund, J.5
Wiklund, I.6
-
12
-
-
84890136859
-
Long-term treatment of hyperphosphatemia with bixalomer in Japanese hemodialysis patients
-
the Bixalomer Study Group
-
Akizawa T, Kameoka C, Kaneko Y, Kawasaki S, the Bixalomer Study Group. Long-term treatment of hyperphosphatemia with bixalomer in Japanese hemodialysis patients. Ther Apher Dial 2013;17:612-619.
-
(2013)
Ther Apher Dial
, vol.17
, pp. 612-619
-
-
Akizawa, T.1
Kameoka, C.2
Kaneko, Y.3
Kawasaki, S.4
|